Highlights
- Telehealth for head and neck cancer (HNC) surveillance is less acceptable immediately post-treatment compared to in-person visits.
- Key barriers include technological challenges, perceived inadequacy of remote assessment, and emotional preference for face-to-face care.
- A hybrid surveillance model combining telehealth and in-person visits increases patient acceptability, particularly beyond two years post-treatment.
- Addressing health literacy and opportunity costs of in-person visits can enhance telehealth integration in HNC surveillance.
Background
